285 related articles for article (PubMed ID: 36008770)
1. Endocapillary hypercellularity levels are associated with early complete remission in children with class IV lupus nephritis as the initial presentation of SLE.
Li C; Han Y; Zhang L; Chen Z; Jin M; Sun S
BMC Nephrol; 2022 Aug; 23(1):296. PubMed ID: 36008770
[TBL] [Abstract][Full Text] [Related]
2. Outcome of reclassification of World Health Organization (WHO) class III under International Society of Nephrology-Renal Pathology Society (ISN-RPS) classification: retrospective observational study.
Hwang J; Kim HJ; Oh JM; Ahn JK; Lee YS; Lee J; Kim YG; Huh WS; Seo J; Koh EM; Cha HS
Rheumatol Int; 2012 Jul; 32(7):1877-84. PubMed ID: 21442173
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes in refractory lupus nephritis: Data from an observational study.
Gururani S; Devarasetti PK; Uppin M; Rajasekhar L
Lupus; 2021 Oct; 30(11):1725-1731. PubMed ID: 34304627
[TBL] [Abstract][Full Text] [Related]
4. Urinary aberrations in systemic lupus erythematosus not always indicative of lupus nephritis: a cross-sectional cohort study.
Karlsson L; Zickert A; Svenungsson E; Schmidt-Mende J; Faustini F; Gunnarsson I
Clin Rheumatol; 2023 Nov; 42(11):2981-2986. PubMed ID: 37439924
[TBL] [Abstract][Full Text] [Related]
5. Long-term renal survival of paediatric patients with lupus nephritis.
Demir S; Gülhan B; Özen S; Çeleğen K; Batu ED; Taş N; Orhan D; Bilginer Y; Düzova A; Ozaltin F; Topaloğlu R
Nephrol Dial Transplant; 2022 May; 37(6):1069-1077. PubMed ID: 33826705
[TBL] [Abstract][Full Text] [Related]
6. Lupus glomerulonephritis in 788 Chinese children: a multi-centre clinical and histopathological analysis based on 549 renal biopsies.
Jin SY; Huang DL; Dang XQ; Yi ZW
Paediatr Int Child Health; 2017 Nov; 37(4):286-291. PubMed ID: 28463080
[TBL] [Abstract][Full Text] [Related]
7. Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis.
Davies RJ; Sangle SR; Jordan NP; Aslam L; Lewis MJ; Wedgwood R; D'Cruz DP
Lupus; 2013 May; 22(6):574-82. PubMed ID: 23632989
[TBL] [Abstract][Full Text] [Related]
8. Early-stage predictors for treatment responses in patients with active lupus nephritis.
Liu G; Wang H; Le J; Lan L; Xu Y; Yang Y; Chen J; Han F
Lupus; 2019 Mar; 28(3):283-289. PubMed ID: 30682900
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the 2018 and 2003 International Society of Nephrology/Renal Pathology Society classification in terms of renal prognosis in patients of lupus nephritis: a retrospective cohort study.
Umeda R; Ogata S; Hara S; Takahashi K; Inaguma D; Hasegawa M; Yasuoka H; Yuzawa Y; Hayashi H; Tsuboi N
Arthritis Res Ther; 2020 Nov; 22(1):260. PubMed ID: 33148339
[TBL] [Abstract][Full Text] [Related]
10. Clinical manifestations, prognosis, and treat-to-target assessment of pediatric lupus nephritis.
Qiu S; Zhang H; Yu S; Yang Q; Zhang G; Yang H; Li Q; Wang M
Pediatr Nephrol; 2022 Feb; 37(2):367-376. PubMed ID: 34379208
[TBL] [Abstract][Full Text] [Related]
11. Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis.
Park DJ; Choi SE; Xu H; Kang JH; Lee KE; Lee JS; Choi YD; Lee SS
Int J Rheum Dis; 2018 Feb; 21(2):458-467. PubMed ID: 29314776
[TBL] [Abstract][Full Text] [Related]
12. Clinico-histomorphologic Characteristics of Lupus Nephritis, Experience at a Center at Dhaka.
Islam SMJ; Rahman AKMM; Yasmin S; Giti S
Saudi J Kidney Dis Transpl; 2021; 32(6):1754-1763. PubMed ID: 35946290
[TBL] [Abstract][Full Text] [Related]
13. Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids.
Condon MB; Ashby D; Pepper RJ; Cook HT; Levy JB; Griffith M; Cairns TD; Lightstone L
Ann Rheum Dis; 2013 Aug; 72(8):1280-6. PubMed ID: 23740227
[TBL] [Abstract][Full Text] [Related]
14. Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis.
Kwon OC; Park JH; Lee SW; Song JJ; Park YB; Park MC
Yonsei Med J; 2020 Nov; 61(11):951-957. PubMed ID: 33107238
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein-2 as a biomarker for lupus nephritis.
Luong PT; Nguyen TTD; Nguyen NT; Ngo HT; Nguyen HN; Pho DH; Nguyen HT
Pediatr Int; 2023; 65(1):e15613. PubMed ID: 37698235
[TBL] [Abstract][Full Text] [Related]
16. Analysis of clinicopathologic correlations in Iranian patients with lupus nephritis.
Shariati-Sarabi Z; Ranjbar A; Monzavi SM; Esmaily H; Farzadnia M; Zeraati AA
Int J Rheum Dis; 2013 Dec; 16(6):731-8. PubMed ID: 24382282
[TBL] [Abstract][Full Text] [Related]
17. Long-term renal outcomes in multi-ethnic Southeast Asians with lupus nephritis: a retrospective cohort study.
Lim CC; Tan HZ; Hao Y; Chin YM; Woo KT; Chan CM; Choo JCJ
Intern Med J; 2018 Sep; 48(9):1117-1123. PubMed ID: 29740923
[TBL] [Abstract][Full Text] [Related]
18. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures.
Wakasugi D; Gono T; Kawaguchi Y; Hara M; Koseki Y; Katsumata Y; Hanaoka M; Yamanaka H
J Rheumatol; 2012 Jan; 39(1):79-85. PubMed ID: 22089455
[TBL] [Abstract][Full Text] [Related]
19. Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis.
Romick-Rosendale LE; Brunner HI; Bennett MR; Mina R; Nelson S; Petri M; Kiani A; Devarajan P; Kennedy MA
Arthritis Res Ther; 2011; 13(6):R199. PubMed ID: 22152586
[TBL] [Abstract][Full Text] [Related]
20. Anti-C1q antibodies in lupus nephritis children with glomerular microthrombosis.
Zhang P; Yang X; Fang X; Xu C; Gao C; Xia Z
Nephrology (Carlton); 2023 Sep; 28(9):485-494. PubMed ID: 37485575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
